As millions of Americans turn to GLP-1 weight-loss medications that suppress their appetite for sweets, Hershey has found an unexpected beneficiary in its mint and gum business — a reminder that markets rarely lose without also finding somewhere new to win. The phenomenon, colloquially called 'Ozempic breath,' points to a quiet truth: when human behavior shifts at scale, even the disrupted adapt. What began as a pharmaceutical revolution in how people eat has quietly become a commercial opportunity in how they manage the aftermath.
CBS News
· Apr 30, 2026
· economy
· 1 min read
High
Sourcing: Verified
Hershey Cashes In on 'Ozempic Breath' as GLP-1 Users Boost Mint Sales
◉
Health & Medicine
8599 related articles
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% match
Rare Kidney Cancer Shows Promise With Immunotherapy, Demands Research …
Oncodaily · 99% match
NIH-developed Sudan virus vaccine shows complete protection in primate…
News-Medical.net · 99% match
GLP-1 drugs linked to lower breast cancer risk, but experts urge cauti…
The Indian Express · 99% match
CDC warns Congo Ebola outbreak could exceed West Africa crisis without…
Devdiscourse · 99% match
Related Coverage
The Guardian · Aug 28
H5 bird flu spreads to dolphins as Australia evacuates Antarctic researchers over mass seal death fears
A dolphin died from H5 bird flu in South Australia, the second native mammal species infected. Australia evacuated 24 re…
The Guardian · Aug 28 Japanese paramedics ask people to stop tidying their shoes during emergenciesKanazawa fire department urges residents not to tidy paramedics' shoes during emergencies, as repositioning footwear can…
Al Jazeera · Aug 28 Algeria mourns 12 dead as massive wildfire outbreak sweeps northeastern provincesOver 150 wildfires erupted across Algeria in a single day, killing 12 people across multiple provinces. Residents in Jij…
Al Jazeera · Aug 28 DRC launches Ebola vaccination drive with untested vaccine as outbreak spiralsThe DRC has begun vaccinating frontline healthcare workers against Ebola using a vaccine licensed for a different strain…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
This article discusses domestic U.S. consumer trends and corporate earnings, not geopolitical matters; no international implications exist.
Escalation Risk
N/A
Confidence
HIGH
Economic Lens
📈
Hershey reports 8% mint/gum sales growth driven by GLP-1 drug users seeking breath fresheners for 'Ozempic breath' side effects, creating a niche market opportunity offsetting reduced candy consumption.
Market Signal
mixed
Confidence
MED
Confectionery and Gum Manufacturing
Pharmaceutical (GLP-1 drugs)
Oral Care Products
Consumer Packaged Goods
GLP-1 users face increased costs for breath fresheners to manage side effects, while non-users may benefit from lower candy consumption trends. Creates new functional snacking category, potentially increasing overall oral care spending among this demographic.
FDA and pharmaceutical regulators may need to formally document halitosis as a GLP-1 side effect and require labeling updates. Could prompt increased scrutiny of undisclosed side effects and drive demand for comprehensive patient education materials on GLP-1 medications.